Atezolizumab in a first-line setting in non-small-cell lung cancer with high PD-L1  expression

Bull Cancer. 2021 Sep 28:S0007-4551(21)00310-6. doi: 10.1016/j.bulcan.2021.06.011. Online ahead of print.NO ABSTRACTPMID:34598788 | DOI:10.1016/j.bulcan.2021.06.011
Source: Bulletin du Cancer - Category: Cancer & Oncology Authors: Source Type: research